Cargando…

Immune‐mediated inflammatory diseases of the gastrointestinal tract: Beyond Crohn's disease and ulcerative colitis

Immune‐mediated inflammatory diseases (IMIDs) are a diverse group of complex inflammatory diseases that result from dysregulated immune pathways and can involve any system of the human body. Inflammatory bowel disease (IBD) is one such disease involving the gastrointestinal (GI) system. With high pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vuyyuru, Sudheer K, Kedia, Saurabh, Sahu, Pabitra, Ahuja, Vineet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Publishing Asia Pty Ltd 2022
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829105/ https://www.ncbi.nlm.nih.gov/pubmed/35155819 http://dx.doi.org/10.1002/jgh3.12706

Ejemplares similares

Efficacy and tolerability of hyperbaric oxygen therapy in small bowel stricturing Crohn’s disease: a pilot study
por: Kante, Bhaskar, et al.
Publicado: (2022)

Real world analysis on the efficacy and safety of anti-tumor necrosis factor therapy in patients with stricturing Crohn’s disease
por: Vuyyuru, Sudheer K., et al.
Publicado: (2021)

Correlation of fecal calprotectin and patient-reported outcome measures in patients with ulcerative colitis
por: Kamat, Nagesh, et al.
Publicado: (2022)

Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn’s disease
por: Sharma, Sanchit, et al.
Publicado: (2021)

Body Composition in Crohn's Disease and Ulcerative Colitis: Correlation with Disease Severity and Duration
por: Yadav, Dawesh P., et al.
Publicado: (2017)

Long‐term outcomes of anti‐tumor necrosis factor therapy and surgery in nonperianal fistulizing Crohn's disease
por: Vuyyuru, Sudheer K, et al.
Publicado: (2021)

Familial aggregation of inflammatory bowel disease in patients with ulcerative colitis
por: Gupta, Akshita, et al.
Publicado: (2017)

Intestinal tuberculosis or Crohn's disease: Illusion or delusion or allusion
por: Kedia, Saurabh, et al.
Publicado: (2021)

Long-term Gastrointestinal Sequelae Following COVID-19: A Prospective Follow-up Cohort Study
por: Golla, Rithvik, et al.
Publicado: (2023)

Addition of computed tomography chest increases the diagnosis rate in patients with suspected intestinal tuberculosis
por: Kedia, Saurabh, et al.
Publicado: (2022)

Interferon-gamma release assay has poor diagnostic accuracy in differentiating intestinal tuberculosis from Crohn’s disease in tuberculosis endemic areas
por: Sachdeva, Karan, et al.
Publicado: (2023)

High mucosal cytomegalovirus DNA helps predict adverse short-term outcome in acute severe ulcerative colitis
por: Jain, Saransh, et al.
Publicado: (2021)

Development and Validation of a Smartphone Application for Telenutrition in Patients with Inflammatory Bowel Disease
por: Gupta, Arti, et al.
Publicado: (2022)

Impact of Cigarette Smoking on the Gastrointestinal Tract Inflammation: Opposing Effects in Crohn’s Disease and Ulcerative Colitis
por: Berkowitz, Loni, et al.
Publicado: (2018)

Does the road to primary prevention of inflammatory bowel disease start from childhood?
por: Kedia, Saurabh, et al.
Publicado: (2022)

High seroprevalence against SARS-CoV-2 in non-vaccinated patients with inflammatory bowel disease from Northern India
por: Kante, Bhaskar, et al.
Publicado: (2023)

Su1075: SIMILAR RISK OF INFECTION WITH SARS-COV-2 IN IMMUNOCOMPROMISED AND IMMUNOCOMPETENT PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND HEALTHY CONTROLS
por: Kante, Bhaskar, et al.
Publicado: (2022)

Maintaining infliximab induced clinical remission with azathioprine and 5-aminosalicylates in acute severe steroid-refractory ulcerative colitis has lower cost and high efficacy (MIRACLE): a multicenter study
por: Mahajan, Ramit, et al.
Publicado: (2022)

Differentiating Crohn’s disease from intestinal tuberculosis
por: Kedia, Saurabh, et al.
Publicado: (2019)

Differential prevalence of pathobionts and host gene polymorphisms in chronic inflammatory intestinal diseases: Crohn’s disease and intestinal tuberculosis
por: Khan, Imteyaz Ahmad, et al.
Publicado: (2021)

Management of inflammatory bowel disease in older persons: evolving paradigms
por: Kedia, Saurabh, et al.
Publicado: (2018)

Crohn's disease of the gastrointestinal tract /
por: Schachter, Howard
Publicado: (1980)

Serum albumin is the strongest predictor of anti-tumor necrosis factor nonresponse in inflammatory bowel disease in resource-constrained regions lacking therapeutic drug monitoring
por: Kumar, Peeyush, et al.
Publicado: (2023)

Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease
por: Sood, Ajit, et al.
Publicado: (2020)

Crohn's disease and ulcerative colitis Surgical management
por: Wilkinson, A J
Publicado: (1996)

Mucosal Barrier in Ulcerative Colitis and Crohn's Disease
por: Dorofeyev, A. E., et al.
Publicado: (2013)

The safety of vedolizumab for ulcerative colitis and Crohn's disease
por: Colombel, Jean-Frédéric, et al.
Publicado: (2017)

Ulcerative Colitis and Crohn's Disease: Similarities and Distinctions
por: Sawyerr, Af M, et al.
Publicado: (1994)

Review of pregnancy in Crohn’s disease and ulcerative colitis
por: Laube, Robyn, et al.
Publicado: (2021)

Ozanimod Therapy in a Patient With Ulcerative Colitis and Multiple Sclerosis: Hitting 2 Birds With 1 Stone
por: Vuyyuru, Sudheer K., et al.
Publicado: (2023)

Inflammatory Bowel Diseases (Crohn´s Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications
por: Kostić, Marina, et al.
Publicado: (2016)

Inflammatory Biomarkers of Extracellular Matrix Remodeling and Disease Activity in Crohn’s Disease and Ulcerative Colitis
por: Domislovic, Viktor, et al.
Publicado: (2022)

Urinary potassium is a potential biomarker of disease activity in Ulcerative colitis and displays in vitro immunotolerant role
por: Goyal, Sandeep, et al.
Publicado: (2017)

Fecal microbiota transplantation refurbishes the crypt-associated microbiota in ulcerative colitis
por: Markandey, Manasvini, et al.
Publicado: (2023)

Expressing the Differences between Crohn Disease and Ulcerative Colitis
por: Wijmenga, Cisca
Publicado: (2005)

Carbohydrate Intake in the Etiology of Crohn's Disease and Ulcerative Colitis
por: Chan, Simon S. M., et al.
Publicado: (2014)

The Changing Prognosis of Ulcerative Colitis and Crohn Disease by Decades
por: Korelitz, Burton I, et al.
Publicado: (2021)

Diagnosis of Crohn’s disease and ulcerative colitis using the microbiome
por: Kang, Da-Yeon, et al.
Publicado: (2023)

Indirect costs of inflammatory bowel diseases: Crohn's disease and ulcerative colitis. A systematic review
por: Kawalec, Paweł
Publicado: (2016)

Inflammatory Potential of the Diet and Incidence of Crohn’s Disease and Ulcerative Colitis in the EPIC-Spain Cohort
por: Guevara, Marcela, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c88mtoi3tsm0k38p3f75pb9bji